(Q24240034)

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Valproate in the treatment of behavioral agitation in elderly patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Sodium valproate in the treatment of behavioral disturbance in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

An open trial of valproate for agitation in geriatric neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

The effects of sodium valproate on disturbed behavior in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

A description of agitation in a nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Valproic acid treatment of agitation in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

The development of an observer-scale for measuring social dysfunction and aggression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

The Overt Aggression Scale for the objective rating of verbal and physical aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Valproate preparations for agitation in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

Valproic Acid for Physically Aggressive Behavior in Geriatric Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

7 January 2021

Sodium valproate and cognitive function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

7 January 2021

Pharmacological Treatment of Agitation in a Nursing Home

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

7 January 2021

Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003945.PUB3

7 January 2021

10.1002/14651858.CD003945.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

19588348

1 reference

Consolidated OpenCitations Corpus – April 2017